
Onc.AI offers Onclara
Onclara, an oncology AI platform for clinical-trial decision-making, trains predictive, prognostic models on real-world oncology data; Evaluate is FDA-breakthrough designated.

Onclara, an oncology AI platform for clinical-trial decision-making, trains predictive, prognostic models on real-world oncology data; Evaluate is FDA-breakthrough designated.
The Onclara platform from Onc.AI trains predictive and prognostic AI models using an oncology real-world dataset and is an oncology AI platform from privately held digital health company Onc.AI.
Onclara Evaluate holds FDA-breakthrough designation for Phase IB and Phase II clinical trial decision-making for pharma companies, while Onclara IO predicts outcomes and response for patients with metastatic lung cancer receiving immunotherapy. Onc.AI's deep learning imaging AI for oncology decision-making serves both clinical trials and clinical practice.


MRAI Diagnostic Solutions for Hospitals & Clinics is an oncology clinical decision-support solution for hospitals and clinics.
MRAI Diagnostic Solutions for Hospitals & Clinics is an oncology clinical decision-support solution for hospitals and clinics.



AI Metrics is AI-enabled radiology software for cancer imaging reads for radiologists that generates patient reports automatically during the study.



OncRef Clinical is a point-of-care oncology reference for oncology clinicians, with content curated by oncologists.


ONCOassist is an application supporting clinical decisions for oncology professionals.
AI Metrics is AI-enabled radiology software for cancer imaging reads for radiologists that generates patient reports automatically during the study.

OpenEvidence is an AI copilot serving doctors at the point of care.

OncRef Clinical is a point-of-care oncology reference for oncology clinicians, with content curated by oncologists.

ONCOassist is an application supporting clinical decisions for oncology professionals.
